Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Security class unavailable · CUSIP: M96088105
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,735,741
- Percent of class
- 8.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-006395
- Form type
- SC 13G
- Filer
- Adage Capital Management, L.P.
- CIK
- CIK 1535978
- Filed
- Nov 12, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership